期刊文献+

从“7+1”论治类风湿关节炎 被引量:9

Treating Rheumatoid Arthritis BY Pattern Identification
原文传递
导出
摘要 将类风湿关节炎辨证为"7+1",即风寒湿热瘀痰毒七邪与肾虚;治疗当予祛风、散寒、祛湿、清热、化瘀、蠲饮、解毒,以及益肾。在此指导思想下,经30余年的临床实践,总结出治疗类风湿关节炎的经验方"羌活地黄汤"。 Pattern of rheumatoid arthritis should be divided into "7+1" mode: wind,cold,dampness,heat,stasis,phlegm,toxic material,and kidney deficiency.During the treatment,the therapy of expelling wind-damp,dissipating cold,alleviating fever,dissipating blood stasis,eliminating rheum,detoxification and boosting kidney should be applied.Under the guiding of this theory,we have formulated the prescription for treating rheumatoid arthritis——"Qianghuo Dihuang Decoction"during the past 30 years of clinical practice.
出处 《上海中医药大学学报》 CAS 2010年第2期1-3,共3页 Academic Journal of Shanghai University of Traditional Chinese Medicine
基金 上海市基础研究重点资助项目(08JC1418800)
关键词 类风湿关节炎 名医经验 沈丕安 羌活地黄汤 Rheumatoid arthritis experience of famous physician Shen Pian "Qianghuo Dihuang Decoction"
  • 相关文献

参考文献3

二级参考文献12

  • 1Boileau C, Amiable N, Martel-Pelletier J, at al. Activation of proteinase-activated receptor 2 in human osteoarthritic cartilage upregulates catabolic and proinflammatory pathways capable of inducing cartilage degradation: a basic science study [J]. Arthritis Res Ther, 2007, 9(6): R121.
  • 2Lee CH, Butt YK, Wong MS, et al. A lipid extract of Perna canaliculus affects the expression of pro-inflammatory eytokines in a rat adjuvant-induced arthritis model [J]. Eur Ann Allergy Clin Immunol, 2008, 40(4): 148-153.
  • 3Kevorkian L, Young DA, Darrah C, et al. Expression profiling of metalloproteinases and their inhibitors in cartilage [J]. Arthritis Rheum, 2004, 50(1): 131-41.
  • 4Ahmed S, Wang N, Hafeez BB, et al. Extract inhibits IL- 1beta-induced expression of matrix metalloproteinases by inhibiting the activation of MAP kinases and NF-kappaB in human chondrocytes in vitro [J]. J Nutr, 2005, 135(9): 2096-2102.
  • 5Klatt AR, Klinger G, Neumuller O, et al. TAK1 downregulation reduces IL-1beta induced expression of MMP13, MMP1 and TNF-alpha. Biomed Pharmacother[J], 2006, 60(2): 55-61.
  • 6Tchetverikov I, Lohmander LS, Verzijl N, et al. MMP protein and activity levels in synovial fluid fi-om patients with joint injury, inflammatory arthritis, and osteoarthntis [J]. Ann Rheum Dis, 2005, 64(5): 694-698.
  • 7Lee Y J, Lee EB, Kwon YE, et al. Effect of estrogen on the expression of matrix metalloproteinase (MMP)- 1, MMP-3, and MMP- 13 and tissue inhibitor of metalloproternase- 1 in osteoarthritis chondrocytes[J]. Rheumatol Int, 2003, 23(6): 282-288.
  • 8American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis: 2002 Update. Arthritis Rheum. 2002; 46(2): 328-346.
  • 9Koh ET, Seow A, Pong LY, Koh WH, Chan L, Howe HS, Lim TH, Low CK. Cross cultural adaptation and validation of the Chinese Health Assessment Questionnaire for use in rheumatoid arthritis. J Rheumatol. 1998; 25(9): 1705-1708.
  • 10Albert DA, Huang G, Dubrow G, Brensinger CM, Berlin JA, Williams HJ. Criteria for improvement in rheumatoid arthritis: alternatives to the American College of Rheumatology 20. J Rheumatol. 2004; 31 (5) : 856-866.

共引文献20

同被引文献95

引证文献9

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部